JPY 1327.0
(1.3%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 6.49 Billion JPY | 11.57% |
2022 | 5.81 Billion JPY | 14.57% |
2021 | 5.07 Billion JPY | -4.34% |
2020 | 5.3 Billion JPY | 66.93% |
2019 | 3.18 Billion JPY | 5.43% |
2018 | 3.01 Billion JPY | 1.94% |
2017 | 2.95 Billion JPY | 41.6% |
2016 | 2.09 Billion JPY | 25.84% |
2015 | 1.66 Billion JPY | 19.89% |
2014 | 1.38 Billion JPY | 34.92% |
2013 | 1.02 Billion JPY | 6.19% |
2012 | 966.97 Million JPY | 10.37% |
2011 | 876.1 Million JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 6.34 Billion JPY | -2.23% |
2023 Q2 | 6.06 Billion JPY | 10.61% |
2023 Q3 | 5.91 Billion JPY | -2.52% |
2023 Q4 | 6.49 Billion JPY | 9.83% |
2023 FY | 6.49 Billion JPY | 11.57% |
2023 Q1 | 5.48 Billion JPY | -5.78% |
2022 Q1 | 4.76 Billion JPY | -6.23% |
2022 FY | 5.81 Billion JPY | 14.57% |
2022 Q4 | 5.81 Billion JPY | 21.36% |
2022 Q2 | 4.9 Billion JPY | 3.07% |
2022 Q3 | 4.79 Billion JPY | -2.32% |
2021 Q1 | 4.8 Billion JPY | -9.51% |
2021 FY | 5.07 Billion JPY | -4.34% |
2021 Q2 | 5.5 Billion JPY | 14.6% |
2021 Q4 | 5.07 Billion JPY | 13.14% |
2021 Q3 | 4.48 Billion JPY | -18.46% |
2020 Q1 | 3.13 Billion JPY | -1.41% |
2020 Q2 | 5.06 Billion JPY | 61.47% |
2020 FY | 5.3 Billion JPY | 66.93% |
2020 Q3 | 4.72 Billion JPY | -6.76% |
2020 Q4 | 5.3 Billion JPY | 12.47% |
2019 Q1 | 2.56 Billion JPY | -15.03% |
2019 Q3 | 2.61 Billion JPY | -22.36% |
2019 FY | 3.18 Billion JPY | 5.43% |
2019 Q4 | 3.18 Billion JPY | 21.61% |
2019 Q2 | 3.36 Billion JPY | 31.42% |
2018 Q1 | 2.76 Billion JPY | -6.66% |
2018 FY | 3.01 Billion JPY | 1.94% |
2018 Q4 | 3.01 Billion JPY | 9.77% |
2018 Q3 | 2.74 Billion JPY | 1.48% |
2018 Q2 | 2.7 Billion JPY | -1.95% |
2017 FY | 2.95 Billion JPY | 41.6% |
2017 Q1 | 1.95 Billion JPY | -6.71% |
2017 Q4 | 2.95 Billion JPY | 27.17% |
2017 Q2 | 2.27 Billion JPY | 16.44% |
2017 Q3 | 2.32 Billion JPY | 2.49% |
2016 Q2 | 1.61 Billion JPY | 2.53% |
2016 Q4 | 2.09 Billion JPY | 31.26% |
2016 FY | 2.09 Billion JPY | 25.84% |
2016 Q1 | 1.57 Billion JPY | -5.36% |
2016 Q3 | 1.59 Billion JPY | -1.19% |
2015 Q4 | 1.66 Billion JPY | 45.43% |
2015 Q2 | 1.43 Billion JPY | 11.95% |
2015 Q3 | 1.14 Billion JPY | -20.38% |
2015 Q1 | 1.28 Billion JPY | -7.51% |
2015 FY | 1.66 Billion JPY | 19.89% |
2014 Q2 | 1.34 Billion JPY | 27.88% |
2014 FY | 1.38 Billion JPY | 34.92% |
2014 Q1 | 1.04 Billion JPY | 2.23% |
2014 Q3 | 1.13 Billion JPY | -15.73% |
2014 Q4 | 1.38 Billion JPY | 22.46% |
2013 Q4 | 1.02 Billion JPY | 29.3% |
2013 Q3 | 794.12 Million JPY | -20.72% |
2013 Q2 | 1 Billion JPY | 5.89% |
2013 Q1 | 946 Million JPY | -2.17% |
2013 FY | 1.02 Billion JPY | 6.19% |
2012 Q2 | 898 Million JPY | 0.0% |
2012 Q4 | 966.97 Million JPY | 25.21% |
2012 Q3 | 772.25 Million JPY | -14.0% |
2012 FY | 966.97 Million JPY | 10.37% |
2011 FY | 876.1 Million JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | -292.839% |
Euglena Co., Ltd. | 37.92 Billion JPY | 82.879% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 55.472% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 69.614% |
Kao Corporation | 757.7 Billion JPY | 99.143% |
Niitaka Co., Ltd. | 9.35 Billion JPY | 30.609% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 93.451% |
Shiseido Company, Limited | 615.1 Billion JPY | 98.944% |
Lion Corporation | 188.22 Billion JPY | 96.551% |
Mandom Corporation | 20.05 Billion JPY | 67.628% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | -389.335% |
Milbon Co., Ltd. | 7.45 Billion JPY | 12.964% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | 52.121% |
Fancl Corporation | 30.56 Billion JPY | 78.761% |
KOSÉ Corporation | 88.61 Billion JPY | 92.674% |
Cota Co., Ltd. | 3.85 Billion JPY | -68.521% |
HABA Laboratories,Inc. | 3.92 Billion JPY | -65.452% |
C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -106.186% |
Pola Orbis Holdings Inc. | 33.26 Billion JPY | 80.48% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 72.994% |
Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -510.145% |
Almado, Inc. | 1.94 Billion JPY | -233.568% |
I-ne CO., LTD. | 8.57 Billion JPY | 24.312% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | -33.043% |
Liberta Co.,Ltd. | 3.88 Billion JPY | -67.178% |
AXXZIA Inc. | 2 Billion JPY | -223.58% |
S.T. Corporation | 12.01 Billion JPY | 45.945% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 89.638% |
Earth Corporation | 60.4 Billion JPY | 89.252% |
Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | 16.744% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -302.499% |
Ya-Man Ltd. | 3.97 Billion JPY | -63.275% |
MTG Co., Ltd. | 11.73 Billion JPY | 44.693% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | -55.618% |
SHOBIDO Corporation | 8.89 Billion JPY | 27.028% |
Artnature Inc. | 23.42 Billion JPY | 72.286% |
Pigeon Corporation | 19.34 Billion JPY | 66.445% |
Unicharm Corporation | 345.37 Billion JPY | 98.12% |
Paltac Corporation | 222.34 Billion JPY | 97.08% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 77.231% |